City

Baltimore (1)

Chicago (1)

Gainesville (1)

Salt Lake City (1)

San Diego (1)

San Francisco (1)

Washington (1)

Condition

Diffuse Intrinsic Pontine Glioma (DIPG) (3)

Brain Stem Glioma (1)

Overall Status

Completed (2)

Recruiting (1)

Phase

phase 1 (2)

n/a (1)

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)

University of California, San Francisco (1)

University of Florida (1)

Collaborator

Accelerate Brain Cancer Cure (1)

Lyla Nsouli Foundation (1)

Solving Kids' Cancer (1)

Translational Genomics Research Institute (1)

Intervention

autologous hematopoietic stem cells (hsc) (1)

cyclophosphamide + fludarabine lymphodepletive conditioning (1)

dose-intensified tmz (1)

melphalan hydrochloride (1)

specialized tumor board recommendation (1)

standard radiation therapy (1)

td vaccine (1)

ttrna-dc vaccines with gm-csf (1)

ttrna-xalt (1)

Study Documents

Intervention Type

drug (2)

biological (1)

other (1)

radiation (1)

Funder Type

Other (3)

Study Type

Interventional (3)

diffuse intrinsic pontine glioma (dipg)

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Diffuse Intrinsic Pontine Glioma (DIPG) Trial in United States (Specialized tumor board recommendation, Standard radiation

Completed

Diffuse Intrinsic Pontine Glioma (DIPG)

Specialized tumor board recommendation
Standard radiation therapy

San Diego, California
+4 more

Nov 2, 2022

Diffuse Intrinsic Pontine Glioma (DIPG), Brain Stem Glioma Trial in Gainesville (TTRNA-DC vaccines with GM-CSF, TTRNA-xALT,

Recruiting

Diffuse Intrinsic Pontine Glioma (DIPG)
Brain Stem Glioma

TTRNA-DC vaccines with GM-CSF
+5 more

Gainesville, Florida

UF Health Shands Children's Hospital

Apr 29, 2022

Diffuse Intrinsic Pontine Glioma (DIPG) Trial in Baltimore (Melphalan HCl)

Completed

Diffuse Intrinsic Pontine Glioma (DIPG)

Melphalan hydrochloride

Baltimore, Maryland

The Johns Hopkins Hospital

Mar 26, 2019